Tumor-associated trypsin inhibitor

被引：0
|
作者：
Stenman, UH [1 ]
机构：
[1] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00029 Helsinki, Finland
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Tumor-associated trypsin inhibitor (TATI) is a low-molecular-weight (6 kDa) trypsin inhibitor that has been used as a marker for ovarian cancer. It is also expressed together with tumor-associated trypsin by many other tumors, and increased serum concentrations of TATI occur in connection with these. TATI is a prognostic marker for ovarian, bladder, and kidney cancer, which may be associated with the participation of trypsin in protease cascades contributing to tumor invasiveness. (C) 2002 American Association for Clinical Chemistry.
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [1] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR AND TUMOR-ASSOCIATED TRYPSIN
    STENMAN, UH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1990, 50 : 93 - 101
  • [2] Tumor-associated trypsin inhibitor (TATI) and renal function
    Tramonti, G
    Ferdeghini, M
    Donadio, C
    Annichiarico, C
    Norpoth, M
    Bianchi, R
    Bianchi, C
    KIDNEY INTERNATIONAL, 1997, : S179 - S181
  • [3] A PROTEASE REACTING WITH A TUMOR-ASSOCIATED TRYPSIN-INHIBITOR
    STENMAN, UH
    KOIVUNEN, E
    VAAHTOKARI, A
    HALILA, H
    TUMOR BIOLOGY, 1987, 8 (06) : 313 - 313
  • [4] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR IN PANCREATIC DISEASES
    AROASIO, E
    PIANTINO, P
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 71 - 73
  • [5] Tumor-associated trypsin inhibitor in patients with endometrial cancer
    Kozakiewicz, Barbara
    Chadzynska, Malgorzata
    Dmoch-Gajzlerska, Ewa
    Stefaniak, Malgorzata
    TUMORI, 2016, 102 (05) : 527 - 532
  • [6] Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays
    Janeiro, Elisabete
    Guimaraes, Joana
    Stenman, Ulf-Hakan
    Catarino, Manuela
    Itkonen, Outi
    CLINICA CHIMICA ACTA, 2012, 413 (15-16) : 1244 - 1248
  • [7] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PLEURAL EFFUSIONS
    RAPELLINO, M
    PECCHIO, F
    BALDI, S
    ADAMO, MR
    MACRI, M
    RICARDI, G
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 47 - 49
  • [8] BIOLOGY AND FUNCTION OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR, TATI
    STENMAN, UH
    KOIVUNEN, E
    ITKONEN, O
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 5 - 9
  • [9] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR IN OVARIAN CYSTIC TUMORS
    HALILA, H
    HAGLUND, C
    NORDLING, S
    STENMAN, UH
    TUMOUR BIOLOGY, 1986, 7 (04): : 242 - 242
  • [10] Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer
    Kasurinen, Aaro
    Laitinen, Alli
    Kokkola, Arto
    Stenman, Ulf-Hakan
    Bockelman, Camilla
    Haglund, Caj
    ACTA ONCOLOGICA, 2020, 59 (06) : 681 - 688
12345